Press Releases September 9, 2026 07:00 AM

Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026

Balchem Corporation to Present at Wells Fargo Consumer Conference on September 23, 2026

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
BCPC

Balchem Corporation, a global specialty ingredient manufacturer serving health and nutrition markets, announced its participation in the 9th Annual Wells Fargo Consumer Conference. Senior executives including the CEO, CFO, and Senior Director of Investor Relations will present, highlighting the company's multi-segment operations across human nutrition, animal health, and specialty products.

Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026
BCPC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Balchem will participate in the Wells Fargo Consumer Conference on September 23, 2026, providing direct investor engagement.
  • The company operates in three main segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, serving diverse markets.
  • Senior leadership involvement underscores a strategic communication effort to discuss company performance and outlook.

MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact:Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)



Risks

  • Market reception to the conference presentation could vary, possibly impacting investor sentiment in the health and nutrition sectors.
  • Economic or regulatory changes affecting the food, supplement, pharmaceutical, animal health, and agricultural supply chains may impact Balchem's operations.
  • Competition and innovation pace in specialty ingredients markets could pose ongoing challenges to growth.

More from Press Releases

Raytech Holding Limited Announces Official Name Change to “Atlas Trinity Tech Limited” and New Ticker Symbol “ATTT” Effective September 10, 2026 Sep 9, 2026 Smithfield® Expands Commonwealth Clash Presenting Sponsorship with New Fan and Community Initiatives Sep 9, 2026 AIM ImmunoTech Highlights Scientific Rationale, Supportive Data and Continued Advancement of Ampligen® in Pancreatic Cancer in New CEO Corner Video Sep 9, 2026 Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada’s GLP-1 Program Sep 9, 2026 T3 Defense to Present at the H.C. Wainwright Global Investment Conference on September 14-16 Sep 9, 2026